Menopause Drug Duavee May Help Prevent Invasive Breast Cancer, Clinical Trial Finds

Menopause drug Duavee may help prevent invasive breast cancer, clinical trial finds

A drug already approved by the FDA to treat menopause symptoms may also help prevent invasive breast cancer, according to new findings from a multi-center phase 2 clinical trial led by Northwestern Medicine.

NU clinical trial: Duavee may help prevent invasive breast cancer   - Evanston RoundTable

Submitted by NorthwesternA drug already approved by the FDA to treat menopause symptoms may also help prevent invasive breast cancer, according to new findings from a multi-center phase 2 clinical trial led by Northwestern Medicine.Dr. Swati Kulkarni, lead investigator and professor of breast surgery at Northwestern University Feinberg School of Medicine, will present the findings Sunday, June 1, at the American Society of Clinical Oncology Annu…

Clinical Trial Suggests Menopause Drug Duavee Could Help Prevent Invasive

A Common Menopause Drug Shows Promise in Preventing Invasive Breast Cancer An innovative clinical trial spearheaded by researchers at Northwestern Medicine has revealed unexpected potential for a drug already approved to treat menopausal symptoms. The findings, soon to be presented at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, suggest that Duavee — a combination therapy of conjugated estrogens and bazedoxife…

Male Breast Cancer Patient Story | Breast Cancer Research Foundation

Attorney Mark credits research for allowing him to keep doing what he loves during and after treatment for breast cancer“I tend to live my life as if I haven’t had it,” Mark Lutes said about having navigated cancer since the late 1980s, when he was first diagnosed and treated for testicular cancer.About two decades later, Mark—an attorney and breadwinner for his wife, Jean, and their four children—felt a suspicious lump in his breast. Jean said …

Menopause drug may help prevent invasive breast cancer, clinical trial finds

A drug already approved by the FDA to treat menopause symptoms may also help prevent invasive breast cancer, according to new findings from a multi-center phase 2 clinical trial led by Northwestern Medicine.